Log in or Sign up for Free to view tailored content for your specialty!
Depression News
HHS awards 1-year, $1M community behavioral health grants to 15 states
HHS announced it has awarded $1 million 1-year Certified Community Behavioral Health Clinic planning grants to 15 states through the Substance Abuse and Mental Health Services Administration.
Patients with lung cancer, depression have higher inflammation levels
Moderate to severe depression in patients with lung cancer was linked to elevated inflammation levels, and the biomarkers measuring inflammation predicted poor survival, according to study results published in PLOS ONE.
Log in or Sign up for Free to view tailored content for your specialty!
Temporal self-, reflected appraisal differs between people with depression, euthymic mood
Temporal self-appraisals and reflected appraisals were not similar in people with depression, but were similar in people with euthymic mood, according to data published in the Journal of Affective Disorders.
Family bereavement program for kids linked to less depression 15 years later
The prevalence of major depression was lower among bereaved children 15 years after participating in a family bereavement program compared with children who did not partake in the program, data showed.
Aiberry secures $8M to promote AI-powered mental health screening platform
A Seattle-based company announced it has secured $8 million in seed funding to promote an artificial intelligence-powered platform to assist in mental health assessments.
Antidepressant augmentation improved well-being compared with switch in adults with TRD
In older adults with treatment-resistant depression, antidepressant augmentation improved well-being significantly over 10 weeks compared with switching medications and was associated with higher incidence of remission.
Symptom remission with IV ketamine quicker than intranasal esketamine in TRD
For individuals diagnosed with treatment-resistant depression, response and remission rates for IV ketamine and intranasal esketamine were similar, but remission time was quicker with the former compared with the latter.
FDA will not hold advisory committee meeting on zuranolone NDA
The FDA announced it does not plan to hold an advisory committee meeting on Sage and Biogen’s new drug application for zuranolone to treat major depressive disorder and postpartum depression in adults.
HHS awards emergency funds to Ohio town affected by train derailment
HHS announced it has awarded $250,000 in emergency funding to Community Action Agency of Columbiana County to assist with behavioral and other health concerns for those affected by the train derailment in East Palestine, Ohio.
FDA grants breakthrough device designation for at-home depression treatment
The FDA has granted breakthrough device designation to a Finnish medical company for its portable, patient-administered neuromodulation device to treat depression.
-
Headline News
‘We have a home’: Physician aims to create network of women allergists
November 14, 20245 min read -
Headline News
Diversified portfolios allow for ‘smoother ride’
November 14, 20243 min read -
Headline News
Predelivery concussion linked to increased risk for severe maternal mental illness
November 12, 20242 min read
-
Headline News
‘We have a home’: Physician aims to create network of women allergists
November 14, 20245 min read -
Headline News
Diversified portfolios allow for ‘smoother ride’
November 14, 20243 min read -
Headline News
Predelivery concussion linked to increased risk for severe maternal mental illness
November 12, 20242 min read